Fresenius Medical Care is a global provider of products and services for individuals with renal diseases. The company operates along the entire dialysis value chain, offering dialysis machines, dialyzers, and related disposables, while also managing a network of dialysis centers for patient care. Its product portfolio includes hemodialysis systems such as the 5008 CAREsystem and 6008 CAREsystem, peritoneal dialysis solutions, and home dialysis technologies acquired through the NxStage Medical acquisition. The company serves patients worldwide through its own clinics and supplies healthcare professionals across numerous countries. Key subsidiaries include the Renal Research Institute and Fresenius Medical Care Ventures, which supports clinical research and innovation in chronic kidney failure. Founded from the merger of Fresenius Worldwide Dialysis and National Medical Care, the company has a history tracing back to the 18th century with the Hirsch Pharmacy. It produces synthetic polysulfone fiber membranes and PVC-free materials like Biofine for dialyzers. The company collaborates with academic institutions and start-ups to expand its technology network in renal therapies.

Summarised from the company's own disclosures, fiscal year ended Oct 2026

Industry Medical Devices Homepage freseniusmedicalcare.com
Sector Healthcare IR page freseniusmedicalcare.com/en/investors
Tags
dialysis, renal care, hemodialysis, peritoneal dialysis, dialyzers, dialysis machines, home dialysis, chronic kidney disease, medical disposables, clinical research, Fresenius Worldwide Dialysis, National Medical Care, Renal Care Group, IDC, Liberty Dialysis Holdings, American Access Care, NxStage Medical, Renal Research Institute, Fresenius Medical Care Ventures, 5008 CAREsystem, 6008 CAREsystem, 4008A, 5008X, sleep•safe harmony, PD Plus, Biofine, Safe●Lock, A2008
Press page —

Metrics

Valuation  
Market cap € 10.982B
Market cap (USD) $ 12.068B
P/E 12.02
PEG 0.57
P/BV 0.81
P/S 0.57
P/OCF 5.90
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 7.9%
ROI 8.3%
ROIC 9.6%
Profit margin —
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) 21.0%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 6.3%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009
Revenue 19.628B 19.336B 19.454B 19.398B 17.619B 17.859B 17.477B 16.547B 17.784B — — 3.972B 3.754B — — — —
Net profit 978.367M 537.913M 498.997M 673.405M 969.308M 1.164B 1.2B 1.982B 1.28B 1.113B 926.051M 788.547M 838.172M 949.261M 758.23M 757.93M 623.041M
Free cash flow 1.766B 1.687B 1.944B 1.443B 1.635B — 1.442B 1.005B 1.247B 993.965M 905.954M 701.414M 971.823M 1.091B 600.712M 654.121M 534.859M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009
Share price 20.26 20.61 19.14 16.23 27.54 35.55 33.12 27.85 44.74 37.8 37.64 28.02 26.87 27.44 48.12 44.69 37.06
Price performance 12m 0.05 0.09 0.27 -0.5 -0.22 0.13 0.14 -0.38 0.25 0.01 0.13 0.04 0.04 -0.5 0.18 0.09 —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) 3.52B — — — — — — — — —
↳ YoY growth +7.3%
↳ 5y CAGR +4.7%
Borrowings, current (USD) 1.66B — — — — — — — — —
Borrowings, non-current (USD) 7.2B — — — — — — — — —
Cash and deposits (USD) 747M — — — — — — — — —
Intangible assets (USD) 847M — — — — — — — — —
Net debt (borrowings + leases - cash) (USD) 8.11B — — — — — — — — —
Cash flow detail
Operating cash flow (USD) 2.14B — — — — — — — — —
Purchases of property, plant and equipment (USD) -1.03B — — — — — — — — —
Change in receivables (cash effect) (USD) 242M — — — — — — — — —
Change in inventories (cash effect) (USD) 66.7M — — — — — — — — —
Change in payables (cash effect) (USD) 45.7M — — — — — — — — —
Dividends paid (cash effect) (USD) 277M — — — — — — — — —
Interest paid (cash effect) (USD) -387M — — — — — — — — —
Income taxes paid (cash effect) (USD) -599M — — — — — — — — —
Share-based compensation (USD) 25.7M — — — — — — — — —
Operating cash flow before change in receivables (USD) 1.9B — — — — — — — — —
Free cash flow (OCF - PPE - intangibles) (USD) 1.11B — — — — — — — — —
Income detail
Research and development expense (USD) 162M 131M 134M 168M 194M 221M 229M 232M 183M 158M
↳ 5y CAGR +7.9% +11.8% +11.7% +1.8% -4.0%
Total comprehensive income (USD) 1.56B — — — — — — — — —
Comprehensive income to owners (USD) 1.26B — — — — — — — — —
Reported Feb 22, 2017 Feb 27, 2018 Feb 20, 2019 Feb 20, 2020 Feb 23, 2021 Feb 22, 2022 Feb 22, 2023 Feb 20, 2024 Feb 25, 2025 Feb 24, 2026

Operating KPIs — quarters

KPI Dec 23 Mar 24 Jun 24 Dec 24 Mar 25 Jun 25 Dec 25 Mar 26
Employees 119,845 117,128 113,639 111,513 112,035 112,445 109,698 108,165
↳ YoY growth -6.4% -6.5% -7.0% -4.3% -1.1% -1.6% -3.5%
Reported Feb 25, 2025 May 7, 2024 Aug 5, 2025 Feb 25, 2025 May 6, 2025 Aug 5, 2025 Feb 24, 2026 May 5, 2026

Operating KPIs — years

KPI Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Employees 125,364 122,909 128,044 119,845 111,513 109,698
↳ YoY growth +3.9% -2.0% +4.2% -6.4% -7.0% -1.6%
Reported Feb 23, 2021 Feb 22, 2022 Feb 21, 2023 Feb 25, 2025 Feb 25, 2025 Feb 24, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

: Release of a capital market information Bull 0 Bear 0 Capital return
: Release of a capital market information Bull 1 Bear 0 Capital return
Dr. Dominik Heger Bull 1 Bear 0 Financing

T +49 6172 609 2525

[email protected]

Fresenius Medical Care places bond with a volume of 500 million Euros

Bad Homburg (November 9, 2026) – Fresenius Medical Care (FME), the world’s leading provider of products and services for individuals with renal diseases, today successfully placed a bond with a volume of €500 million. The bond maturing in February 2032 and a coupon of 4.250% p.a. was issued at a price of 99.497% resulting in a yield of 4.363% p.a.

The proceeds will be used for general corporate purposes, including the refinancing of existing financial liabilities.

The bond was issued under Fresenius Medical Care’s Debt Issuance Programme (DIP), and the company has applied to the Luxembourg Stock Exchange to admit the bond to trading on its regulated market.

The envisaged settlement date is November 16, 2026.

About Fresenius Medical Care:

Fresenius Medical Care is the world's leading provider of products and services for individuals with renal diseases of which around 4.5 million patients worldwide regularly undergo dialysis treatment. Through its network of 3,512 dialysis clinics, Fresenius Medical Care provides dialysis treatments for approx.

Prompts

Fresenius Medical Care AG (ticker FME), listed in Germany.

Company History

Date Change Detail
Nov 30, 2023 Renamed FRESENIUS MEDICAL CARE AG & CO. KGAA → FRESENIUS MEDICAL CARE AG
Dec 31, 2017 Reporting currency Its US reports are in EUR instead of USD from this period. Earlier figures are shown in EUR, converted at each period end's exchange rate.

ETFs Holding Fresenius Medical Care AG

ETF Weight in ETF Shares Market value As of
BINV 1.86% 201,152 $ 9.101M Jun 30, 2026
SAGP 1.59% 26,832 $ 1.215M Jun 30, 2026
TIIV 1.11% 14,239 $ 365.373K Jul 31, 2026
DISV 0.62% 713,557 $ 31.239M Nov 12, 2026
DTAN 0.53% 2,638 $ 115.304K Nov 17, 2026
SEIE 0.36% 90,971 $ 4.119M Jun 30, 2026
RINT 0.24% 7,302 $ 330.393K Jun 30, 2026
AIVI 0.23% 3,041 $ 137.68K Jun 30, 2026
DFIS 0.21% 274,214 $ 12.005M Nov 12, 2026
NBIE 0.16% 8,884 $ 407.093K Aug 31, 2026
DXIV 0.16% 8,628 $ 377.725K Nov 12, 2026
GMOI 0.12% 18,080 $ 828.482K Aug 31, 2026
DFIV 0.09% 453,595 $ 19.825M Nov 12, 2026
DFIC 0.09% 308,010 $ 13.484M Nov 12, 2026
APIE 0.06% 30,718 $ 698.527K Aug 31, 2026
DFAX 0.06% 153,476 $ 6.719M Nov 12, 2026
DFSI 0.05% 12,663 $ 554.373K Nov 12, 2026
NTSI 0.04% 4,390 $ 198.756K Jun 30, 2026
DFAI 0.04% 163,362 $ 7.074M Nov 12, 2026
FENI 0.02% 44,469 $ 2.012M Jun 30, 2026
AVDE 0.01% 71,810 $ 1.57M Nov 16, 2026
AVSD 0.00% 641 $ 14.012K Nov 16, 2026

Securities

Ticker Type Class Market Exchange Last price Price date
FMS Common share — US nyse 22.38 USD 2026-09-30
FME canonical Common share — DE xetra 40.40 EUR 2026-10-30